UCPVax是一种CD4辅助疫苗,诱导多功能Th1细胞,抗体反应和表皮质扩散以改善抗瘤免疫力
Caroline Laheurte1, Laura Boullerot1, Babacar Ndao1
1Université Marie et Louis Pasteur, EFS, INSERM, UMR RIGHT, 25000 Besançon, France.
Cell reports. Medicine
|June 21, 2025
概括
一种新的癌症疫苗UCPVax有效地激活CD4+T细胞来对抗瘤. 这种疫苗诱导了强大的免疫反应,导致持久的抗瘤免疫力和改善癌症治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 疫苗学 疫苗学 疫苗学
背景情况:
- CD4+ T辅助细胞的反应对于治疗癌症疫苗的有效性至关重要.
- 很少有疫苗专门针对人类癌症中的CD4+T细胞.
- 端粒酶是癌症疫苗的目标.
研究的目的:
- 描述UCPVax的免疫机制,这是一个来自端粒酶的辅助疫苗.
- 评估UCPVax在晚期肺癌患者中激活CD4+T细胞的能力.
- 评估UCPVax对抗瘤免疫力的影响.
主要方法:
- 从60名肺癌患者的外周血液进行了ex vivo免疫分析.
- 使用单细胞技术分析CD4+T细胞激活和分化.
- 评估细胞因子多功能性,表皮质扩散和抗体反应.
主要成果:
- 在体内,UCPVax通过广泛的HLA-DR限制选择性地激活了CD4+ T细胞.
- 疫苗诱导了一种协同免疫反应,包括多功能CD4+Th1细胞,表皮质扩散和抗体产生.
- UCPVax促进了CD4+T细胞向效应记忆和细胞分解表型的分化,有助于瘤控制.
结论:
- 通过激活CD4+T细胞,UCPVax诱导了广泛和持久的抗瘤免疫力.
- UCPVax代表了一种有效的现成辅助平台,用于提高癌症疫苗的疗效.
- 用UCPVax准CD4+T细胞有望改善治疗癌症疫苗接种策略.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.4K
07:18HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
Published on: April 11, 2011
15.5K
相关概念视频
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Vaccinations
45.3K
Overview
45.3K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Immune Response Against Viral Pathogens
916
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
916
